Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Carolina Díez
Observed name:
C. Díez
Institutions:
Hospital Universitario de León,
Complejo Asistencial Universitario de León
Observed institutions:
Hospital El Bierzo,
Hospital Universitario de León,
Complejo Asistencial Universitario de León
ORCID:
0000-0001-5472-4299
Observed ORCID:
0000-0001-5472-4299
OpenAlex ID:
A5018129641
Apremilast in refractory orogenital ulcers and other manifestations of Behçet's disease. National multicenter study of 51 cases in clinical practice.
2020
·
Belén Atienza-Mateo
, José Luis Martín-Varillas
, et al.
·
9
PDF
AB0507 Belimumab in patients with systemic lupus erythematosus: outcomes in routine clinical practice
2018
·
C. Moriano
, M. Garijo
, et al.
·
Annals of the Rheumatic Diseases
·
6
PDF
Sat0215 Apremilast in Refractory Oral And/or Genital Ulcers in Behçet's Disease. Multicenter Study of 49 Cases in Clinical Practice
2019
·
Belén Atienza-Mateo
, José Luis Martín-Varillas
, et al.
·
Annals of the Rheumatic Diseases
·
3
PDF
Pos0835 Effectiveness and Safety of Jak Inhibitors in Rheumatoid Arthritis-interstitial Lung Disease. National Multicenter Study of 57 Patients
2023
·
A. Serrano-Combarro
, B. Atienza-Mateo
, et al.
·
Annals of the Rheumatic Diseases
·
2
PDF
Pos0599 Rheumatoid Arthritis-progressive Interstitial Lung Disease With Abatacept: Data From a Large National Multicenter Cohort
2024
·
A. Serrano-Combarro
, B. Atienza-Mateo
, et al.
·
Annals of the Rheumatic Diseases
·
1
Ab1191 Kl-6 and Il-18 as Diagnostic Markers for Interstitial Lung Disease in Systemic Sclerosis: Outperforming Traditional Assessments for Improved Risk Stratification and Early Detection
2024
·
C. Sieiro Santos
, S. Calleja Antolín
, et al.
·
Annals of the Rheumatic Diseases
·
1
Pos0831 Predictive Significance of Biomarkers in Systemic Sclerosis-associated Interstitial Lung Disease: Insights Into Progression, Lung Volume Changes, and Mortality Risk
2024
·
M. Retuerto-Guerrero
, C. Sieiro Santos
, et al.
·
Annals of the Rheumatic Diseases
·
1
Op0126 Long-term Follow up of Abatacept in Usual Interstitial Pneumonia Associated to Rheumatoid Arthritis. National Multicenter Study of 172 Patients
2023
·
B. Atienza-Mateo
, A. Serrano-Combarro
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Thu0307 Response of Behçet's Refractory Oral And/or Genital Ulcers to Apremilast in Combination Vs Monotherapy. National Multicenter Study of 51 Cases of Clinical Practice
2020
·
A. Herrero Morant
, B. Atienza Mateo
, et al.
·
Annals of the Rheumatic Diseases
·
1
PDF
Ab1483 Nintedanib in Progressive Pulmonary Fibrosis. Comparing Subgroups in Clinical Practice. Experience of Pulmonologists and Rheumatologists
2024
·
P. Pérez-García
, M. Retuerto-Guerrero
, et al.
·
Annals of the Rheumatic Diseases
Ab1474 Nintedanib in Autoimmune Disease-related Interstitial Lung Disease: Real-life Effectiveness, Safety and Tolerance in a Spanish Multicenter Study
2024
·
P. Pérez-García
, M. Retuerto-Guerrero
, et al.
·
Annals of the Rheumatic Diseases
Ab0694 Baricitinib in Rheumatoid Arthritis-interstitial Lung Disease. National Multicenter Study of 60 Patients
2024
·
A. Serrano-Combarro
, B. Atienza-Mateo
, et al.
·
Annals of the Rheumatic Diseases
Pos1286 Autoantibody and Radiological Profiles as Prognostic Indicators in Idiopathic Inflammatory Myopathies: Insights Into Mortality and Interstitial Lung Disease Development
2024
·
C. Sieiro Santos
, M. Retuerto-Guerrero
, et al.
·
Annals of the Rheumatic Diseases
Pos0864 Effectiveness of Antifibrotics in Rheumatoid Arthritis-interstitial Lung Disease. National Multicenter Study of 50 Patients in Clinical Practice
2023
·
B. Atienza-Mateo
, A. Serrano-Combarro
, et al.
·
Annals of the Rheumatic Diseases
PDF
Pos0035 Influence of Interstitial Lung Disease Duration on the Treatment of Rheumatoid Arthritis-interstitial Lung Disease. National Multicenter Study of 392 Patients With Abatacept
2023
·
A. Serrano-Combarro
, B. Atienza-Mateo
, et al.
·
Annals of the Rheumatic Diseases
PDF
Ab0416 Subcutaneus Vs Intravenous Abatacept in Rheumatoid Arthritis-interstitial Lung Disease. National Multicenter Study of 392 Patients
2023
·
A. Serrano-Combarro
, B. Atienza-Mateo
, et al.
·
Annals of the Rheumatic Diseases
PDF
Fri0487 Apremilast in Monotherapy or Combined in Non-ulcer Manifestations of Behçet's Disease. National Multicenter Study of 34 Refractory Cases of Clinical Practice
2020
·
A. Herrero Morant
, B. Atienza Mateo
, et al.
·
Annals of the Rheumatic Diseases
PDF
FRI0270 APREMILAST IN NON-ULCER MANIFESTATIONS IN BEHçET'S DISEASE. MULTICENTER STUDY OF 32 CASES IN CLINICAL PRACTICE
2019
·
Belén Atienza-Mateo
, José Luis Martín-Varillas
, et al.
·
Annals of the Rheumatic Diseases
PDF
FRI0489 Utility of apremilast in refractory oral and/or genital ulcers in behÇet's disease
2018
·
B. Atienza-Mateo
, J. Loricera
, et al.
·
Annals of the Rheumatic Diseases
PDF
Show more works
View as search
Works count:
19
Citation count:
25
H-index:
3
I10-index:
Year
Topic
Type